OncomiR or antioncomiR: Role of miRNAs in Acute Myeloid Leukemia

References

• Estey E, Döhner H. Acute myeloid leukaemia. The Lancet. 2006;368:1894–1907.
   PubMed Web of Science ®Google Scholar
• De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer Journal. 2016;6:e441.
   PubMed Web of Science ®Google Scholar
• Palma CA, Tonna EJ, Ma DF, et al. MicroRNA control of myelopoiesis and the differentiation block in acute myeloid leukaemia. J Cell Mol Med. 2012;16:978–987.
   PubMed Web of Science ®Google Scholar
• Seca H, Almeida GM, Guimaraes JE, et al. miR signatures and the role of miRs in acute myeloid leukaemia. Eur J Cancer. 2010;46:1520–1527.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Piletic K, Kunej T. MicroRNA epigenetic signatures in human disease. Arch Toxicol. 2016;90:2405–2419.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li X, Ke Z, et al. MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia. Cancer Cell Int. 2013;13:110.
   PubMed Web of Science ®Google Scholar
• M H, QY W, QQ Y, et al. HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation. Cell Death & Differentiation. 2013;20:408.
   PubMed Web of Science ®Google Scholar
• Liu L, Ren W, Chen K. MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells. Cell Physiol Biochem. 2017;41:1981–1992.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Xu X. Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1. Transl Oncol. 2017;10:410–418.
   PubMed Web of Science ®Google Scholar
• Lu F, Zhang J, Ji M, et al. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1. Int J Oncol. 2014;45:383–392.
   PubMed Web of Science ®Google Scholar
• Jiang X, Huang H, Li Z, et al. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2012;109:19397–19402.
   PubMed Web of Science ®Google Scholar
• Sun YP, Lu F, Han XY, et al. MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1. Oncotarget. 2016;7:25276–25290.
   PubMedGoogle Scholar
• Li Y, Zhu X, Gu J, et al. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Hematology. 2010;15:215–221.
   PubMed Web of Science ®Google Scholar
• Gu J, Zhu X, Li Y, et al. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Med Oncol. 2011;28:211–218.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Y. Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells. Cell Physiol Biochem. 2015;37:641–650.
   PubMed Web of Science ®Google Scholar
• Liu J, Guo B, Chen Z, et al. miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism. Blood. 2017;129:1491–1502.
   PubMed Web of Science ®Google Scholar
• Bousquet M, Nguyen D, Chen C, et al. MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA. Haematologica. 2012;97:1713–1721.
   PubMed Web of Science ®Google Scholar
• Zhang H, Luo XQ, Feng DD, et al. Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia. Mol Cancer. 2011;10:108.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tang P, Chen Y, et al. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-kappaB signaling pathway. Biochem Biophys Res Commun. 2017;488:60–66.
   PubMed Web of Science ®Google Scholar
• Li Z, Huang H, Chen P, et al. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun. 2012;3:688.
   Google Scholar
• Shah NM, Zaitseva L, Bowles KM, et al. NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival. Cell Death Differ. 2015;22:654–664.
   PubMed Web of Science ®Google Scholar
• Su R, Dong L, Zou D, et al. microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia. Oncogene. 2016;35:6001–6014.
   PubMed Web of Science ®Google Scholar
• Gong JN, Yu J, Lin HS, et al. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia. Cell Death Differ. 2014;21:100–112.
   PubMed Web of Science ®Google Scholar
• Havelange V, Stauffer N, Heaphy CC, et al. Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling. Cancer. 2011;117:4696–4706.
   PubMed Web of Science ®Google Scholar
• Gao SM, Chen C, Wu J, et al. Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide. Biochem Biophys Res Commun. 2010;403:203–208.
   PubMed Web of Science ®Google Scholar
• Gaal Z, Olah E. MicroRNA-s and their role in malignant hematologic diseases. Orv Hetil. 2012;153:2051–2059.
   PubMedGoogle Scholar
• Li Z, Lu J, Sun M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A. 2008;105:15535–15540.
   PubMed Web of Science ®Google Scholar
• Garzon R, Heaphy CE, Havelange V, et al. MicroRNA 29b functions in acute myeloid leukemia. Blood. 2009;114:5331–5341.
   PubMed Web of Science ®Google Scholar
• Yen K, Travins J, Wang F, et al. AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations. Cancer Discov. 2017;7:478–493.
   PubMed Web of Science ®Google Scholar
• Cimmino L, Dolgalev I, Wang Y, et al. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression. Cell. 2017;170:1079–1095 e1020.
   PubMed Web of Science ®Google Scholar
• Stein EM, DiNardo CD, Pollyea DA, et al. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. Blood. 2017;130:722–731.
   PubMed Web of Science ®Google Scholar
• Song SJ, Ito K, Ala U, et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell. 2013;13:87–101.
   PubMed Web of Science ®Google Scholar
• Bai H, Cao Z, Deng C, et al. miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis. J Cancer Res Clin Oncol. 2012;138:595–602.
   PubMed Web of Science ®Google Scholar
• Brauer-Hartmann D, Hartmann JU, Wurm AA, et al. PML/RARalpha-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia. Cancer Res. 2015;75:3411–3424.
   PubMed Web of Science ®Google Scholar
• Eisfeld AK, Schwind S, Patel R, et al. Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway. Sci Signal. 2014;7:ra36.
   PubMed Web of Science ®Google Scholar
• Xu L, Zhong H, Wan H, et al. miR-146a expression level as a novel putative prognostic marker for acute promyelocytic leukemia. Dis Markers. 2014;2014:150604.
   PubMed Web of Science ®Google Scholar
• Yang DQ, Zhou JD, Wang YX, et al. Low miR-34c expression is associated with poor outcome inde novoacute myeloid leukemia. International Journal of Laboratory Hematology. 2017;39:42–50.
   PubMed Web of Science ®Google Scholar
• Favreau AJ, McGlauflin RE, Duarte CW, et al. miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications. Exp Hematol Oncol. 2015;5:4.
   PubMedGoogle Scholar
• Gao SM, Yang J, Chen C, et al. miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid. Leuk Lymphoma. 2011;52:2365–2371.
   PubMed Web of Science ®Google Scholar
• Ghaffari SH, Bashash D, Dizaji MZ, et al. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action. Tumour Biol. 2012;33:157–172.
   PubMedGoogle Scholar
• Liang H, Li X, Wang L, et al. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells. Cell Physiol Biochem. 2013;32:1818–1829.
   PubMed Web of Science ®Google Scholar
• Tian C, You MJ, Yu Y, et al. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tumour Biol. 2016;37:7461–7471.
   PubMedGoogle Scholar
• Chen P, Price C, Li Z, et al. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci U S A. 2013;110:11511–11516.
   PubMed Web of Science ®Google Scholar
• Bryant A, Palma CA, Jayaswal V, et al. miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death. Mol Cancer. 2012;11:8.
   PubMed Web of Science ®Google Scholar
• Sportoletti P, Varasano E, Rossi R, et al. The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. Blood. 2013;121:3447–3458.
   PubMed Web of Science ®Google Scholar
• Espadinha AS, Prouzet-Mauleon V, Claverol S, et al. A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells. Oncotarget. 2017;8:76174–76188.
   PubMedGoogle Scholar
• Gocek E, Wang X, Liu X, et al. MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res. 2011;71:6230–6239.
   PubMed Web of Science ®Google Scholar
• Pan C, Zhu D, Zhuo J, et al. Role of Signal Regulatory Protein alpha in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis. Sci Rep. 2016;6:23710.
   PubMed Web of Science ®Google Scholar
• Sharifi M, Salehi R, Gheisari Y, et al. Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression. Mol Biol Rep. 2014;41:2799–2808.
   PubMed Web of Science ®Google Scholar
• Sharifi M, Salehi R. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia. Cancer Gene Ther. 2016;23:29–35.
   PubMed Web of Science ®Google Scholar
• de Leeuw DC, Denkers F, Olthof MC, et al. Attenuation of microRNA-126 expression that drives CD34 + 38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res. 2014;74:2094–2105.
   PubMed Web of Science ®Google Scholar
• Fang J, Barker B, Bolanos L, et al. Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-kappaB gene network. Cell Rep. 2014;8:1328–1338.
   PubMed Web of Science ®Google Scholar
• Sheng X, Zhong H, Wan H, et al. Granulocyte colony-stimulating factor inhibits CXCR4/SDF-1alpha signaling and overcomes stromal-mediated drug resistance in the HL-60 cell line. Exp Ther Med. 2016;12:396–404.
   PubMed Web of Science ®Google Scholar
• Sun X, Liu D, Xue Y, et al. Enforced miR-144-3p Expression as a Non-Invasive Biomarker for the Acute Myeloid Leukemia Patients Mainly by Targeting NRF2. Clin Lab. 2017;63:679–687.
   PubMed Web of Science ®Google Scholar
• Tian P, Yan L. Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG). Med Sci Monit. 2016;22:5116–5123.
   PubMed Web of Science ®Google Scholar
• Khalife J, Radomska HS, Santhanam R, et al. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia. Leukemia. 2015;29:1981–1992.
   PubMed Web of Science ®Google Scholar
• Zhang H, Goudeva L, Immenschuh S, et al. miR-155 is associated with the leukemogenic potential of the class IV granulocyte colony-stimulating factor receptor in CD34(+) progenitor cells. Mol Med. 2015;20:736–746.
   PubMed Web of Science ®Google Scholar
• Xue H, Hua LM, Guo M, et al. SHIP1 is targeted by miR-155 in acute myeloid leukemia. Oncol Rep. 2014;32:2253–2259.
   PubMed Web of Science ®Google Scholar
• Alachkar H, Santhanam R, Harb JG, et al. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. J Hematol Oncol. 2013;6:21.
   PubMed Web of Science ®Google Scholar
• Liang H, Dong Z, Liu JF, et al. Targeting miR-155 suppresses proliferation and induces apoptosis of HL-60 cells by targeting Slug/PUMA signal. Histol Histopathol. 2017;32:899–907.
   PubMed Web of Science ®Google Scholar
• Xue H, Liang L, Guo HM, et al. Efects of Inhibiting miR-155 Expression on the Proliferation and Apoptosis of Leukemia THP-1 Cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014;22:1550–1554.
   PubMedGoogle Scholar
• Gerloff D, Grundler R, Wurm AA, et al. NF-kappaB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia. Leukemia. 2015;29:535–547.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Maharry KS, Metzeler KH, et al. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol. 2013;31:2086–2093.
   PubMed Web of Science ®Google Scholar
• Liu X, Liao W, Peng H, et al. miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM. J Cancer Res Clin Oncol. 2016;142:77–87.
   PubMed Web of Science ®Google Scholar
• Chen H, Chen Q, Fang M, et al. microRNA-181b targets MLK2 in HL-60 cells. Sci China Life Sci. 2010;53:101–106.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang Q, Shi G, et al. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target. Biomed Pharmacother. 2017;97:1189–1194.
   PubMed Web of Science ®Google Scholar
• Qian J, Lin J, Qian W, et al. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia. Leuk Res. 2013;37:765–768.
   PubMed Web of Science ®Google Scholar
• Deng L, Jiang L, Lin XH, et al. The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia. Acta Pharmacol Sin. 2017;38:382–391.
   PubMed Web of Science ®Google Scholar
• Tarighat SS, Santhanam R, Frankhouser D, et al. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation. Leukemia. 2016;30:789–799.
   PubMed Web of Science ®Google Scholar
• Bernot KM, Nemer JS, Santhanam R, et al. Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease. Blood. 2013;122:3778–3783.
   PubMed Web of Science ®Google Scholar
• Zaidi SK, Perez AW, White ES, et al. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells. Oncotarget. 2017;8:39994–40005.
   PubMedGoogle Scholar
• Abraham M, Klein S, Bulvik B, et al. The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression. Leukemia. 2017;31:2336–2346.
   PubMed Web of Science ®Google Scholar
• Li G, Song Y, Zhang Y, et al. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia. Oncol Res. 2016;24:109–116.
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Dong K, et al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal. 2015;27:443–452.
   PubMed Web of Science ®Google Scholar
• Zauli G, Voltan R, di Iasio MG, et al. miR-34a Induces the Downregulation of Both E2F1 and B-Myb Oncogenes in Leukemic Cells. Clinical Cancer Research. 2011;17:2712–2724.
   PubMed Web of Science ®Google Scholar
• Sun H, Lin DC, Guo X, et al. Inhibition of IRE1alpha-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia. Oncotarget. 2016;7:18736–18749.
   PubMed Web of Science ®Google Scholar
• Gu Y, Si J, Xiao X, et al. miR-92a Inhibits Proliferation and Induces Apoptosis by Regulating Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) Expression in Acute Myeloid Leukemia. Leukemia. 2017;25:1069–1079.
   Google Scholar
• Ufkin ML, Peterson S, Yang X, et al. miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leuk Res. 2014;38:402–410.
   PubMed Web of Science ®Google Scholar
• Seca H, Lima RT, Almeida GM, et al. Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells. Curr Pharm Biotechnol. 2014;15:492–502.
   PubMed Web of Science ®Google Scholar
• Hu Y, Dong X, Chu G, et al. miR-137 downregulates c-kit expression in acute myeloid leukemia. Leuk Res. 2017;57:72–77.
   PubMed Web of Science ®Google Scholar
• Shen JZ, Zhang YY, Fu HY, et al. Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells. Oncol Rep. 2014;31:2035–2042.
   PubMed Web of Science ®Google Scholar
• Fang ZH, Wang SL, Zhao JT, et al. miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways. Cell Death Dis. 2016;7:e2371.
   PubMed Web of Science ®Google Scholar
• Palma CA, Al Sheikha D, Lim TK, et al. MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia. Mol Cancer. 2014;13:79.
   PubMed Web of Science ®Google Scholar
• Tian WL, Jiang ZX, Wang F, et al. IRF3 is involved in human acute myeloid leukemia through regulating the expression of miR-155. Biochem Biophys Res Commun. 2016;478:1130–1135.
   PubMed Web of Science ®Google Scholar
• Hickey CJ, Schwind S, Radomska HS, et al. Lenalidomide-mediated enhanced translation of C/EBPalpha-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia. Blood. 2013;121:159–169.
   PubMed Web of Science ®Google Scholar
• Wang X, Zuo D, Yuan Y, et al. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia. J Cancer Res Clin Oncol. 2017;143:169–180.
   PubMed Web of Science ®Google Scholar
• Ke S, Li RC, Lu J, et al. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2. Int J Hematol. 2017;106:258–265.
   PubMed Web of Science ®Google Scholar
• Li Y, Gao L, Luo X, et al. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood. 2013;121: 499–509.
   PubMed Web of Science ®Google Scholar
• Gao XN, Lin J, Li YH, et al. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Oncogene. 2011;30:3416–3428.
   PubMed Web of Science ®Google Scholar
• Dell'Aversana C, Giorgio C, D'Amato L, et al. miR-194-5p/BCLAF1 deregulation in AML tumorigenesis. 2017;31:2315–2325.
   Google Scholar
• Xiao Y, Deng T, Su C, et al. MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS. Oncol Lett. 2017;13:4986–4994.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Su C, Deng T. miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7. Oncol Lett. 2016;12:3531–3536.
   PubMed Web of Science ®Google Scholar
• Liu X, Heng C, Li Y, et al. MiR-302a sensitizes leukemia cells to etoposide by targeting Rad52. Oncotarget. 2017;8:73884–73891.
   PubMedGoogle Scholar
• Li Z, Huang H, Li Y, et al. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood. 2012;119:2314–2324.
   PubMed Web of Science ®Google Scholar
• Forrest AR, Kanamori-Katayama M, Tomaru Y, et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia. 2010;24:460–466.
   PubMed Web of Science ®Google Scholar
• Kuang X, Wei C, Zhang T, et al. miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes. Int J Oncol. 2016;49: 1921–1930.
   PubMed Web of Science ®Google Scholar
• Su R, Gong JN, Chen MT, et al. c-Myc suppresses miR-451 dash, verticalYWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia. Oncotarget. 2016;7:77430–77443.
   PubMedGoogle Scholar
• Tian C, Zheng G, Zhuang H, et al. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells. J Cell Physiol. 2017;232:1387–1395.
   PubMed Web of Science ®Google Scholar
• Tang S, Pei R, Li K, et al. DNA methylation-mediated epigenetic silencing of miR-720 contributes to leukemogenesis in acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi. 2014;35:1009–1012.
   PubMedGoogle Scholar